参考文献/References:
[1] Kuz'nik A,Paz'dzierniok-Holewa A,Jewula P,et al.Bisphosphonates—much more than only drugs for bone diseases[J].Eur J Pharmacol,2020,866:172773.DOI:10.1016/j.ejphar.2019.172773.
[2] Jacques RM,Boonen S,Cosman F,et al.Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with Postmenop-ausal osteoporosis treated with once-yearly zoledronic acid 5 mg:the HORIZON-Pivotal Fracture Trial(PFT)[J].J Bone Miner Res,2012,27(8):1627-1634.DOI:10.1002/jbmr.1644.
[3] 王文婕,傅文贞,何进卫,等.阿仑膦酸钠与唑来膦酸治疗绝经后骨质疏松症疗效比较[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):445-449.DOI:10.3969/j.issn.1674-2591.2017.05.003.
[4] 宣淼,杨军,李颖,等.唑来膦酸与替勃龙对绝经后骨质疏松症骨密度、骨代谢指标及骨折影响的临床研究[J].中华内分泌代谢杂志,2013,29(6):504-508.DOI:10.3760/cma.j.issn.1000-6699.2013.06.014.
[5] 杨立进,林涌鹏,陈博来,等.唑来膦酸的使用次数与骨密度及临床疗效的相关性[J].广东医学,2018,39(9):1410-1414.DOI:10.3969/j.issn.1001-9448.2018.09.036.
[6] 李子荣.股骨头坏死临床诊疗规范[J].中华骨与关节外科杂志,2015,(1):1-6.DOI:10.3969/j.issn.2095-9958.2015.01-001.
[7] 杜玉清,孔样泉,刘玉卿.骨梗死的影像学表现及其病理基础[J].临床放射学杂志,2004,23(2):143-146.DOI:10.3969/j.issn.1001-9324.2004.02.013.
[8] 郭红丽,陈刚.骨梗死的诊断及手术治疗临床分析[J].中国现代医生,2009,47(25):153-154.DOI:10.3969/j.issn.1673-9701.2009.25.095.
[9] 詹友达,陶金国,卢刚,等.股骨头坏死合并同侧股骨、胫骨骨梗死一例报告[J].中国骨肿瘤骨病,2011,10(6):627-628.DOI:10.3969/j.issn.1671-1971.2011.06.024.
[10] 郑桂敏,王磊,贾秀川,等.结缔组织病合并膝关节骨梗死三例报道[J].上海交通大学学报(医学版),2013,33(2):253-256.DOI:10.3969/j.issn.1674-8115.2013.02.026.
[11] Maslin D,Karanth M,Bhagat S,et al.Successful treatment of transient osteoporosis with intravenous zoledronate:a case report[J]. Int J Rheum Dis,2014,17(7):816-817.DOI:10.1111/1756-185X.12350.
[12] Zywiel MG,McGrath MS,Seyler TM,et al.Osteonecrosis of the knee:a review of three disorders[J]. Orthop Clin North Am,2009,40(2):193-211.DOI:10.1016/j.ocl.2008.10.010.
[13] Mont MA,Marker DR,Zywiel MG,et al.Osteonecrosis of the knee and related conditions[J].J Am Acad Orthop Surg,2011,19(8):482-494.DOI:10.5435/00124635-201108000-00004.
[14] Strauss EJ,Kang R,Bush-Joseph C,et al.The diagnosis and management of spontaneous and post-arthroscopy osteonecrosis of the knee[J].Bull NYU Hosp Jt Dis.2011,69(4):320-330.
[15] Jureus J,Lindstrand A,Geijer M,et al.Treatment of spontaneous osteonecrosis of the knee(SPONK)by a bisphosphonateA prospective case series with 17 patients[J]. Acta Orthopaedica,2012,83(5):511-514.DOI:10.3109/17453674.2012.729184.
[16] al-Rowaih A,Lindstrand A,Björkengren A,et al.Osteonecrosis of the knee:diagnosis and outcome in 40 patients[J].Acra Orthop Scand,1991,62(1):19-23.DOI:10.3109/17453679108993085.
[17] 王竣,黄永明,曹振武,等.唑来膦酸治疗早期膝关节自发性骨坏死疗效分析[J].广东医学,2019,40(9):1221-1224.DOI:10.13820/j.cnki.gdyx.20185822.
[18] Bhatnagar N,Sharma S,Gautam VK,et al.Characteristics,management,and outcomes of spontaneous osteonecrosis of the knee in Indian population[J].Int Orthop,2018,42(7):1499-1508.DOI:10.1007/s00264-018-3878-y.
[19] Little DG,Peat RA,Mcevoy A,et al.Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats[J].J Bone Miner Res,2003,18(11):2016-22.DOI:10.1359/jbmr.2003.18.11.2016.
[20] Tägil M,Astrand J,Westman L,et al.Alendronate prevents collapse in mechanically loaded osteochondral grafts:a bone chamber study in rats[J].Acta Orthop Scand,2004,75(6):756-761.DOI:10.1080/00016470410004157.
[21] Kim HK,Randall TS,Bian H,et al.Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs[J].J Bone Joint Surg Am,2005,87(3):550-557.DOI:10.2106/JBJS.D.02192.
[22] Kim HK,Sanders M,Athavale S,et al.Local bioavailability and distribution of systemically(parenterally)administered ibandronate in the infarcted femoral head[J].Bone,2006,39(1):205-212.DOI:10.1016/j.bone.2005.12.019.
[23] Aya-ay J,Athavale S,Morgan-Bagley S,et al.Retention,distribution,and effects of intraosseously administered ibandronate in the infarcted femoral head[J].J Bone Miner Res,2007,22(1):93-100.DOI:10.1359/jbmr.060817.
[24] Lai KA,Shen WJ,Yang CY,et al.The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis.A randomized clinical study[J].J Bone Joint Surg Am,2005,87(10):2155-2159.DOI:10.2106/JBJS.D.02959.
[25] Agarwala S,Shah S,Joshi VR.The use of alendronate in the treatment of avascular necrosis of the femoral head:follow-up to eight years[J].J Bone Joint Surg Br,2009,91(8):1013-1018.DOI:10.1302/0301-620X.91B8.21518.